Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Ankh Life Sciences describes new anticancer compounds

March 4, 2021

Cancer-associated fibroblasts influence GIST progression and metastasis through PDGFC secretion

March 4, 2021

At ESMO TAT meeting, translating translation inhibition

March 3, 2021

Poziotinib twice daily effective in patients with EGFR/HER2 exon 20-mutant NSCLC

March 3, 2021

Phase I data reported for CC-90010 in patients with solid tumors

March 3, 2021

Applied Pharmaceutical Science identifies new RET inhibitors

March 3, 2021

First-in-human data presented for SCC-244 in NSCLC

March 3, 2021

AbbVie initiates first-in-human study of ABBV-637 as monotherapy or in combination

March 3, 2021

Carna receives CTA clearance for phase I study of BTK inhibitor AS-1763

March 2, 2021

FDA issues complete response letter for oral paclitaxel plus encequidar in metastatic breast cancer

March 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...